Bala Munipalli, M.D.

  1. Internist
  1. Grach SL, Dudenkov DV, Pollack B, Fairweather D, Aakre CA, Munipalli B, Croghan IT, Mueller MR, Overgaard JD, Bruno KA, Collins NM, Li Z, Hurt RT, Tal MC, Ganesh R, Knight DTR. Overlapping conditions in Long COVID at a multisite academic center. Front Neurol. 2024; 15:1482917 Epub 2024 Oct 25
    View PubMed
  2. Munipalli B, Smith A, Baird AR, Dobrowolski CS, Allman ME, Thomas LG, Bruce BK. A description of the development of an innovative multi-component long COVID treatment program based on central sensitization with preliminary patient satisfaction data. J Psychosom Res. 2024 Oct; 185:111884 Epub 2024 Aug 12
    View PubMed
  3. Bala Munipalli, Anjali Morris, Teresa Rummans. A 21-Year-Old-Woman with New Onset Tourette Syndrome after Coronavirus Disease 2019 (COVID-19) Medical Research Archives. 2024; 12(7).
  4. Cheshire WP, Dudenkov DV, Munipalli B. Tilt Table Testing. JAMA. 2024 May 7; 331 (17):1494-1495
    View PubMed
  5. Knight DRT, Bruno KA, Singh A, Munipalli B, Gajarawala S, Solomon M, Kocsis SC, Darakjian AA, Jain A, Whelan ER, Kotha A, Gorelov DJ, Phillips SD, Fairweather D. Cardiac defects of hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders: a retrospective cohort study. Front Cardiovasc Med. 2024; 11:1332508 Epub 2024 Mar 18
    View PubMed
  6. Punj M, Schwartz M, Morris A, Cheung J, Munipalli B. A Survey of Sleep Quality From a Post-COVID Clinic. J Prim Care Community Health. 2024 Jan-Dec; 15:21501319241233205.
    View PubMed
  7. Ganesh R, Munipalli B. Long COVID and hypermobility spectrum disorders have shared pathophysiology. Front Neurol. 2024; 15:1455498 Epub 2024 Sept 05
    View PubMed
  8. Darakjian AA, Bhutani M, Fairweather D, Kocsis SC, Fliess JJ, Khatib S, Weigel GJ, McCabe EJ, Balamurugan V, Perona EE, Gehin JM, Whelan ER, Jain A, Sledge H, Hodge DO, Rozen TD, Farraye FA, Soyer O, Cheung J, Grach SL, Shirey D Jr, Gajarawala S, Munipalli B, Shufelt CL, Knight DRT, Bruno KA. Similarities and differences in self-reported symptoms and comorbidities between hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders. Rheumatol Adv Pract. 2024; 8 (4):rkae134 Epub 2024 Nov 04
    View PubMed
  9. Munipalli B, Al-Soleiti M, Morris A, Rummans T. COVID-19: ramifications of the pandemic on mental health and substance abuse. Front Public Health. 2024; 12:1401734 Epub 2024 July 31
    View PubMed
  10. Munipalli B, Chauhan M, Morris AM, Ahmad R, Fatima M, Allman ME, Niazi SK, Bruce BK. Recognizing and Treating Major Depression in Fibromyalgia: A Narrative Primer for the Non-Psychiatrist. J Prim Care Community Health. 2024 Jan-Dec; 15:21501319241281221.
    View PubMed
  11. Knight DR, Aakre CA, Anstine CV, Munipalli B, Biazar P, Mitri G, Valery JR, Brigham T, Niazi S, Perlman AI, Halamka JD, Abu AM. Artificial intelligence for patient scheduling in the real-world health care setting: A metanarrative review Health Policy and Technology. 2023; 12(4).
  12. Munipalli B, Ma Y, Li Z, Ganesh R, Knight D, Logvinov II, Paul SN, Delaney TR, Abu Dabrh AM. Risk factors for post-acute sequelae of COVID-19: Survey results from a tertiary care hospital. J Investig Med. 2023 Dec; 71 (8):896-906 Epub 2023 Aug 12
    View PubMed
  13. Prabhakaran D, Day GS, Munipalli B, Rush BK, Pudalov L, Niazi SK, Brennan E, Powers HR, Durvasula R, Athreya A, Blackmon K. Neurophenotypes of COVID-19: Risk factors and recovery outcomes. Brain Behav Immun Health. 2023 Jul; 30:100648 Epub 2023 June 04
    View PubMed
  14. Munipalli B, Paul S, Mohabbat A, Siddiqui H, Li Z, Abu Dabrh AM. Clinical differences in symptomology, characteristics, and risk factors in patients with post-acute sequelae of COVID-19: an experience from a tertiary-care academic center. J Investig Med. 2023 Jun; 71 (5):495-501 Epub 2023 Feb 09
    View PubMed
  15. Rivera FA, Munipalli B, Allman ME, Hodge DO, Wieczorek MA, Wang B, Abril A, Perlman A, Knight D, Bruce B. A retrospective analysis of the prevalence and impact of associated comorbidities on fibromyalgia outcomes in a tertiary care center. Front Med (Lausanne). 2023; 10:1301944 Epub 2024 Jan 15
    View PubMed
  16. Fairweather D, Bruno KA, Darakjian AA, Bruce BK, Gehin JM, Kotha A, Jain A, Peng Z, Hodge DO, Rozen TD, Munipalli B, Rivera FA, Malavet PA, Knight DRT. High overlap in patients diagnosed with hypermobile Ehlers-Danlos syndrome or hypermobile spectrum disorders with fibromyalgia and 40 self-reported symptoms and comorbidities. Front Med (Lausanne). 2023; 10:1096180 Epub 2023 Apr 25
    View PubMed
  17. Ganesh R, Vanichkachorn GS, Munipalli B, Hanson SN, Abu Dabrh AM, Croghan IT, Dawson NL, Hurt RT. Postacute Sequelae of SARS-CoV-2 Infection-Lessons Learned From a Coordinated Health System Response. Mayo Clin Proc Innov Qual Outcomes. 2022 Aug; 6 (4):311-319 Epub 2022 June 01
    View PubMed
  18. Munipalli B, Strothers S, Rivera F, Malavet P, Mitri G, Abu Dabrh AM, Dawson NL. Association of Vitamin B12, Vitamin D, and Thyroid-Stimulating Hormone With Fatigue and Neurologic Symptoms in Patients With Fibromyalgia. Mayo Clin Proc Innov Qual Outcomes. 2022 Aug; 6 (4):381-387 Epub 2022 July 31
    View PubMed
  19. Knight DRT, Munipalli B, Logvinov II, Halkar MG, Mitri G, Dabrh AMA, Hines SL. Perception, Prevalence, and Prediction of Severe Infection and Post-acute Sequelae of COVID-19. Am J Med Sci. 2022 Apr; 363 (4):295-304 Epub 2022 Jan 10
    View PubMed
  20. Munipalli B, Shah JS. Unusual presentation of stiff-person syndrome in a patient with type 1 diabetes mellitus. BMJ Case Rep. 2022 Feb 7; 15 (2) Epub 2022 Feb 07
    View PubMed
  21. Munipalli B, Seim L, Dawson NL, Knight D, Dabrh AMA. Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management. SN Compr Clin Med. 2022; 4 (1):90 Epub 2022 Apr 04
    View PubMed
  22. Knight DRT, Confiado SM, Bruno KA, Fairweather D, Seymour-Sonnier AM, Jain A, Gehin JM, Whelan ER, Culberson JH, Munipalli B, Dawson NL, Rozen TD, Wick JJ, Kotha A. Establishing an Ehlers-Danlos Syndrome Clinic: Lessons Learned. SN Compr Clin Med. 2022; 4 (1):138 Epub 2022 July 05
    View PubMed
  23. Munipalli B, Allman ME, Chauhan M, Niazi SK, Rivera F, Abril A, Wang B, Wieczorek MA, Hodge DO, Knight D, Perlman A, Abu Dabrh AM, Dudenkov D, Bruce BK. Depression: A Modifiable Risk Factor for Poor Outcomes in Fibromyalgia. J Prim Care Community Health. 2022 Jan-Dec; 13:21501319221120738.
    View PubMed
  24. Munipalli B, Knight D, Logvinov I, Abu Dabrh AM. Prevalence, Demographics, and Risk of Severe Acute COVID-19. Cureus. 2021 Oct; 13 (10):e18851 Epub 2021 Oct 18
    View PubMed
  25. Malouff TD, TerKonda SP, Knight D, Abu Dabrh AM, Perlman AI, Munipalli B, Dudenkov DV, Heckman MG, White LJ, Wert KM, Pascual JM, Rivera FA, Shoaei MM, Leak MA, Harrell AC, Trifiletti DM, Buskirk SJ. Physician Satisfaction With Telemedicine During the COVID-19 Pandemic: The Mayo Clinic Florida Experience. Mayo Clin Proc Innov Qual Outcomes. 2021 Aug; 5 (4):771-782 Epub 2021 July 01
    View PubMed
  26. Knight D, Downes K, Munipalli B, Halkar MG, Logvinov II, Speicher LL, Hines SL. Symptoms and Clinical Outcomes of Coronavirus Disease 2019 in the Outpatient Setting. SN Compr Clin Med. 2021; 3 (1):247-254 Epub 2021 Jan 14
    View PubMed
  27. Munipalli B. Clinical Module/Question/Discussion for Retinitis Pigmentosa Core Content Review of Family Medicine. 2013; 44(2):85.
  28. Munipalli B. Clinical Module/Question/Discussion for Temper Tantrums Core Content Review of Family Medicine. 2013; 43(4):162-163.
  29. Munipalli B. Clinical Model/Question/Discussion for Temporal Arteritis Core Content Review of Family Medicine. 2012; 43(3):94-95.
  30. Munipalli B. Hereditary Hemachromatosis Core Content Review of Family Medicine. 2012; 43(2):13-19.
  31. Munipalli B, Wilson G. Incidental adrenal adenoma Core Content Review of Family Medicine. 2010; 6(7):14-19.
  32. Munipalli B, Rinaldi MG, Greenberg SB. Cokeromyces recurvatus isolated from pleural and peritoneal fluid: case report. J Clin Microbiol. 1996 Oct; 34 (10):2601-3
    View PubMed
  33. Arem R, Munipalli B. Ipodate therapy in patients with severe destruction-induced thyrotoxicosis. Arch Intern Med. 1996 Aug 12-26; 156 (15):1752-7
    View PubMed